These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14626291)

  • 1. The tolerability of viscosupplementation: low incidence and clinical management of local adverse events.
    Waddell DD
    Curr Med Res Opin; 2003; 19(7):575-80. PubMed ID: 14626291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability and short-term effectiveness of hylan G-F 20 in 4253 patients with osteoarthritis of the knee in clinical practice.
    Kemper F; Gebhardt U; Meng T; Murray C
    Curr Med Res Opin; 2005 Aug; 21(8):1261-9. PubMed ID: 16083536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hylan G-F 20 tolerability with repeat treatment in a large orthopedic practice: a retrospective review.
    Waddell DD; Bricker DC
    J Surg Orthop Adv; 2006; 15(1):53-9. PubMed ID: 16603113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viscosupplementation with hylan G-F 20 (Synvisc): pain and mobility observations from 74 consecutive patients.
    Lee S; Park D; Chmell SJ
    J Knee Surg; 2004 Apr; 17(2):73-7. PubMed ID: 15124659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: a pilot study.
    Conrozier T; Jerosch J; Beks P; Kemper F; Euller-Ziegler L; Bailleul F; Chevalier X
    Arch Orthop Trauma Surg; 2009 Mar; 129(3):417-23. PubMed ID: 18365224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: a randomized controlled trial.
    Jüni P; Reichenbach S; Trelle S; Tschannen B; Wandel S; Jordi B; Züllig M; Guetg R; Häuselmann HJ; Schwarz H; Theiler R; Ziswiler HR; Dieppe PA; Villiger PM; Egger M;
    Arthritis Rheum; 2007 Nov; 56(11):3610-9. PubMed ID: 17968921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hylan G-F 20 Versus Low Molecular Weight Hyaluronic Acids for Knee Osteoarthritis: A Meta-Analysis.
    Zhao H; Liu H; Liang X; Li Y; Wang J; Liu C
    BioDrugs; 2016 Oct; 30(5):387-396. PubMed ID: 27435213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience with the effectiveness and tolerability of hylan G-F 20 in 1047 patients with osteoarthritis of the knee.
    Waddell DD; Bricker DC
    J Knee Surg; 2006 Jan; 19(1):19-27. PubMed ID: 16468490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscosupplementation for the treatment of osteoarthritis of the knee.
    Bellamy N; Campbell J; Robinson V; Gee T; Bourne R; Wells G
    Cochrane Database Syst Rev; 2005 Apr; (2):CD005321. PubMed ID: 15846754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intra-articular hylan G-F 20 injections on clinical and biomechanical characteristics of the knee in osteoarthritis.
    Yavuzer G; Sonel B; Süldür N; Ergin S
    Int J Rehabil Res; 2005 Dec; 28(4):371-4. PubMed ID: 16319566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review.
    Espallargues M; Pons JM
    Int J Technol Assess Health Care; 2003; 19(1):41-56. PubMed ID: 12701938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee.
    Hammesfahr JF; Knopf AB; Stitik T
    Am J Orthop (Belle Mead NJ); 2003 Jun; 32(6):277-83. PubMed ID: 12834190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up.
    Waddell DD; Cefalu CA; Bricker DC
    J Knee Surg; 2005 Jan; 18(1):7-15. PubMed ID: 15742592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of repeat courses of hylan G-F 20 in patients with knee osteoarthritis.
    Raynauld JP; Goldsmith CH; Bellamy N; Torrance GW; Polisson R; Belovich D; Pericak D; Tugwell P
    Osteoarthritis Cartilage; 2005 Feb; 13(2):111-9. PubMed ID: 15694572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year efficacy and safety of single or one to three weekly injections of hylan G-F 20 for knee osteoarthritis: a systematic literature review and meta-analysis.
    De Lucia O; Jerosch J; Yoon S; Sayre T; Ngai W; Filippou G
    Clin Rheumatol; 2021 Jun; 40(6):2133-2142. PubMed ID: 33108530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open pilot study of ultrasound-guided intra-articular injection of hylan G-F 20 (Synvisc) in the treatment of symptomatic hip osteoarthritis.
    Migliore A; Tormenta S; Martin LS; Valente C; Massafra U; Granata M; Alimonti A
    Clin Rheumatol; 2005 Jun; 24(3):285-9. PubMed ID: 15592903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and performance of Hydros and Hydros-TA for knee osteoarthritis: a prospective, multicenter, randomized, double-blind feasibility trial.
    Petrella RJ; Emans PJ; Alleyne J; Dellaert F; Gill DP; Maroney M
    BMC Musculoskelet Disord; 2015 Mar; 16():57. PubMed ID: 25887932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment.
    Goldberg VM; Coutts RD
    Clin Orthop Relat Res; 2004 Feb; (419):130-7. PubMed ID: 15021143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased frequency of acute local reaction to intra-articular hylan GF-20 (synvisc) in patients receiving more than one course of treatment.
    Leopold SS; Warme WJ; Pettis PD; Shott S
    J Bone Joint Surg Am; 2002 Sep; 84(9):1619-23. PubMed ID: 12208919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.